 |
Parkinson Disease - Therapy
Research News and Information
Definition of 'Parkinson Disease'A progressive, degenerative neurologic disease characterized by a TREMOR that is maximal at rest, retropulsion (i.e. a tendency to fall backwards), rigidity, stooped posture, slowness of voluntary movements, and a masklike facial expression. Pathologic features include loss of melanin containing neurons in the substantia nigra and other pigmented nuclei of the brainstem. LEWY BODIES are present in the substantia nigra and locus coeruleus but may also be found in a related condition (LEWY BODY DISEASE, DIFFUSE) characterized by dementia in combination with varying degrees of parkinsonism. (Adams et al., Principles of Neurology, 6th ed, p1059, pp1067-75) |
Saturday, November 21, 2009
Functional magnetic stimulation in constipation associated with Parkinson's disease.
30 Oct 2009 
OBJECTIVE: The aims of this study were: (i) to investigate the effect of functional magnetic stimulation on total colonic transit time in patients with Parkinson's disease; (ii) to compare the changes in dynamic recto-anal behaviour during filling ... Read more...
29 Sep 2009 OBJECT: The aim of the current study was to examine and compare the aftereffects of local high-frequency microstimulation through the recording electrode on the firing of neurons in the subthalamic nucleus (STN) and the substantia nigra pars ... Read more...
29 Sep 2009 OBJECT: The authors developed a wavelet-based measure for quantitative assessment of neural background activity during intraoperative neurophysiological recordings so that the boundaries of the subthalamic nucleus (STN) can be more easily localized ... Read more...
Latest indexed articles for 'Parkinson Disease - Therapy'
These are the very latest articles for this heading:
- Functional magnetic stimulation in constipation associated with Parkinson's disease. 30 Oct 2009
- Bilateral subthalamotomy through dbs electrodes: A rescue option for device-related infection.
11 Oct 2009 - Microstimulation-induced inhibition as a tool to aid targeting the ventral border of the subthalamic nucleus. 29 Sep 2009
- Identification of the subthalamic nucleus in deep brain stimulation surgery with a novel wavelet-derived measure of neural background activity. 29 Sep 2009
- A novel composite targeting method using high-field magnetic resonance imaging for subthalamic nucleus deep brain stimulation. 29 Sep 2009
- Neuroprotection in a 6-hydroxydopamine-lesioned Parkinson model using lactoferrin-modified nanoparticles. 30 Aug 2009
- [Management of Parkinson's disease in 2009] 24 Aug 2009
- Exercise therapy, quality of life, and activities of daily living in patients with Parkinson disease: a small scale quasi-randomised trial. 9 Aug 2009
- Jean-Martin Charcot and his vibratory chair for Parkinson disease. 9 Aug 2009
- ECT for Parkinson's disease. 3 Aug 2009
- Bilateral effects of unilateral subthalamic deep brain stimulation on Parkinson's disease at 1 year. 30 Jul 2009
- [Parkinson's disease and obsessive-compulsive spectrum]
30 Jul 2009 - Mitochondrial gene therapy augments mitochondrial physiology in a Parkinson's disease cell model. 30 Jul 2009
- Treatment disparities in Parkinson's disease. 30 Jul 2009
- Deep brain stimulation effects in patients with tinnitus. 30 Jul 2009
- Deep brain stimulation for Parkinson's disease: Australian referral guidelines. 30 Jul 2009
- Surgical treatment of movement disorders. 30 Jul 2009
- Micro lesion effect of the globus pallidus internus and outcome with deep brain stimulation in patients with Parkinson disease and dystonia. 28 Jul 2009
- Acute urinary retention in two patients after subthalamic nucleus deep brain stimulation (STN-DBS) for the treatment of advanced Parkinson's disease. 28 Jul 2009
- Subjective visual vertical may be altered by bilateral subthalamic deep brain stimulation. 28 Jul 2009
See a longer list of these articles.
Technical information about 'Parkinson Disease'
Definition: A progressive, degenerative neurologic disease characterized by a TREMOR that is maximal at rest, retropulsion (i.e. a tendency to fall backwards), rigidity, stooped posture, slowness of voluntary movements, and a masklike facial expression. Pathologic features include loss of melanin containing neurons in the substantia nigra and other pigmented nuclei of the brainstem. LEWY BODIES are present in the substantia nigra and locus coeruleus but may also be found in a related condition (LEWY BODY DISEASE, DIFFUSE) characterized by dementia in combination with varying degrees of parkinsonism. (Adams et al., Principles of Neurology, 6th ed, p1059, pp1067-75)
Descriptor UI: D010300
Alternative terms: Parkinson Disease; Idiopathic Parkinson's Disease; Lewy Body Parkinson Disease; Lewy Body Parkinson's Disease; Primary Parkinsonism; Parkinsonism, Primary; Parkinson Disease, Idiopathic; Parkinson's Disease; Parkinson's Disease, Idiopathic; Parkinson's Disease, Lewy Body; Idiopathic Parkinson Disease; Paralysis Agitans;
Related Mesh Headings: Lewy Bodies;
Allowable Qualifiers: blood; cerebrospinal fluid; classification; complications; congenital; diagnosis; diet therapy; drug therapy; economics; embryology; enzymology; ethnology; etiology; genetics; history; immunology; metabolism; microbiology; mortality; nursing; epidemiology; parasitology; pathology; physiopathology; prevention & control; psychology; radiography; radionuclide imaging; radiotherapy; rehabilitation; surgery; therapy; urine; veterinary; ultrasonography; virology;
Tree Number: C10.228.140.079.862.500; C10.228.662.600.400; C10.574.812;
History Note: 1979(1963)
Technical Notes: drug ther: consider also ANTIPARKINSON AGENTS; /chem ind = PARKINSON DISEASE, SECONDARY/chem ind